SIGA Technologies (SIGA) Receives $7.7 Million Grant From the National Institutes of Health
Tweet
Share
E-mailGet Alerts SIGA Hot Sheet
Join SI Premium – FREE
SIGA Technologies, Inc. (Nasdaq: SIGA) announced today that it has been awarded a $7.7 million grant from the National Institutes of Health to develop an antiviral drug for treating and preventing Lassa fever and other hemorrhagic fevers of Arenavirus origin.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Cytek faces $56M damages award in Beckman Coulter patent case
- CoVolt Power files for proposed IPO
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
